SYS-6026

N/A

Report date: 2026/05/12 15:11:39

Base Information

Drug NameSYS-6026
Drug Alias NameSYS6026SYS-6026
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineCell and gene therapy > Gene therapy > mRNAVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProtein E6 inhibitors
TargetsProtein E6
Therapy Area/IndicationsSolid tumoursSquamous Intraepithelial LesionsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJushi Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJushi Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursSquamous Intraepithelial LesionsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A